P

Inventor

DESJARLAIS JOHN R

US88 patents
⚠️ This page may combine multiple inventors who share the name “DESJARLAIS JOHN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

XENCOR INC

23 patents
US8367805B2Feb 5, 2013

Fc variants with altered binding to FcRn

XENCOR INC210 citations99
US8039592B2Oct 18, 2011

Optimized Fc variants and methods for their generation

XENCOR INC86 citations99
US7662925B2Feb 16, 2010

Optimized Fc variants and methods for their generation

XENCOR INC349 citations99
US7657380B2Feb 2, 2010

Methods of generating variant antibodies with increased host string content

XENCOR INC169 citations99
US7317091B2Jan 8, 2008

Optimized Fc variants

XENCOR INC872 citations99
US9701759B2Jul 11, 2017

Heterodimeric proteins

XENCOR INC48 citations98
US8383109B2Feb 26, 2013

Optimized Fc variants and methods for their generation

XENCOR INC40 citations98
US10336818B2Jul 2, 2019

Fc variants with altered binding to FcRn

XENCOR INC47 citations97
US9803023B2Oct 31, 2017

Fc variants with altered binding to FcRn

XENCOR INC62 citations97
US11591401B2Feb 28, 2023

Anti-CD28 compositions

XENCOR INC19 citations93
US9617348B2Apr 11, 2017

Compositions and methods for treating IgE-mediated disorders

XENCOR INC11 citations92
US7610156B2Oct 27, 2009

Methods for rational pegylation of proteins

XENCOR INC29 citations92
US7662367B2Feb 16, 2010

Pharmaceutical compositions for the treatment of TNF-α related disorders

XENCOR INC30 citations90
US7446174B2Nov 4, 2008

Protein based TNF-α variants for the treatment of TNF-α related disorders

XENCOR INC27 citations90
US7244823B2Jul 17, 2007

TNF-alpha variants proteins for the treatment of TNF-alpha related disorders

XENCOR INC49 citations90
US11377477B2Jul 5, 2022

PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof

XENCOR INC7 citations85
US11358999B2Jun 14, 2022

IL-12 heterodimeric Fc-fusion proteins

XENCOR INC12 citations85
US11919958B2Mar 5, 2024

Anti-CD28 compositions

XENCOR INC9 citations84
US10738132B2Aug 11, 2020

Heterodimeric proteins

XENCOR INC9 citations84
US9902773B2Feb 27, 2018

Methods and compositions for inhibiting CD32b expressing cells

XENCOR INC4 citations84
US7930107B2Apr 19, 2011

Methods of generating variant proteins with increased host string content

XENCOR INC13 citations84
US7557190B2Jul 7, 2009

Optimized proteins that target Ep-CAM

XENCOR INC28 citations84
US9803020B2Oct 31, 2017

Optimized antibodies that target CD19

XENCOR INC5 citations83

CHAMBERLAIN AARON KEITH

8 patents

LAZAR GREGORY ALAN

8 patents

CHU SEUNG YUP

5 patents

BERNETT MATTHEW J

3 patents

DESJARLAIS JOHN R

2 patents

PENN STATE RES FOUND

1 patent

Showing the top 50 of 88 patents by PatentIndex Score.